Cargando…

The ankle in XLH: Reduced motion, power and quality of life

BACKGROUND: X-linked hypophosphatemia (OMIM 307800) is a rare bone disease caused by a phosphate-wasting condition with lifelong clinical consequences. Those affected suffer from bone pain, complex skeletal deformities, impaired mobility and a reduced quality of life. Early osteoarthritis and reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akta, Celine, Wenzel-Schwarz, Florian, Stauffer, Alexandra, Kranzl, Andreas, Raimann, Adalbert, Kocijan, Roland, Ganger, Rudolf, Mindler, Gabriel T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073673/ https://www.ncbi.nlm.nih.gov/pubmed/37033213 http://dx.doi.org/10.3389/fendo.2023.1111104

Ejemplares similares

Persistent Lower Limb Deformities Despite Amelioration of Rickets in X-Linked Hypophosphatemia (XLH) - A Prospective Observational Study
por: Mindler, Gabriel T., et al.
Publicado: (2022)

Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia
por: Mindler, Gabriel T., et al.
Publicado: (2021)

Multidisciplinary patient care in X‐linked hypophosphatemic rickets: one challenge, many perspectives
por: Raimann, Adalbert, et al.
Publicado: (2020)

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
por: Seefried, Lothar, et al.
Publicado: (2023)

Decreased Compressional Sound Velocity Is an Indicator for Compromised Bone Stiffness in X-Linked Hypophosphatemic Rickets (XLH)
por: Raimann, Adalbert, et al.
Publicado: (2020)

Correction of post-traumatic lower-limb discrepancy with Precice intramedullary lengthening nails: a review of 34 adults with an average follow-up of 2 years
por: RADLER, Christof, et al.
Publicado: (2022)

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives
por: Seefried, Lothar, et al.
Publicado: (2023)

Influence of femoral anteversion angle and neck-shaft angle on muscle forces and joint loading during walking
por: Kainz, Hans, et al.
Publicado: (2023)

The unstable knee in congenital limb deficiency
por: Mindler, Gabriel T., et al.
Publicado: (2016)

Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
por: Schindeler, Aaron, et al.
Publicado: (2020)

Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy
por: Brener, Rafi, et al.
Publicado: (2022)

Varus deformity of the left lower extremity causing degenerative lesion of the posterior horn of the left medial meniscus in a patient with Paget’s disease of bone
por: Al Kaissi, Ali, et al.
Publicado: (2014)

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
por: Takashi, Yuichi, et al.
Publicado: (2022)

Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023)

Correction of the axial and appendicular deformities in a patient with Silver-Russel syndrome
por: Al Kaissi, Ali, et al.
Publicado: (2015)

Outcomes after thumb carpometacarpal joint stabilization with an abductor pollicis longus tendon strip for the treatment of chronic instability
por: Stauffer, Alexandra, et al.
Publicado: (2019)

X-linked Hypophosphatemia (XLH) Mimicking Rheumatic Disease
por: Takase, Ryosuke, et al.
Publicado: (2020)

Phenotypes of a family with XLH with a novel PHEX mutation
por: Yamamoto, Akiko, et al.
Publicado: (2020)

SUN-363 Hypophosphatemia Gene Panel Sponsored Program: A High Yield Of Molecular Diagnoses from Clinically Confirmed XLH and Suspected XLH/ Genetic Hypophosphatemia
por: Miller, Nicole, et al.
Publicado: (2020)

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
por: Mughal, M. Zulf, et al.
Publicado: (2023)

Expanding the Phenotype of the FAM149B1-Related Ciliopathy and Identification of Three Neurogenetic Disorders in a Single Family
por: Siegert, Sandy, et al.
Publicado: (2021)

Young XLH Patients-Reported Experience with a Supportive Care Program
por: Rothenbuhler, Anya, et al.
Publicado: (2023)

SUN-523 XLH Outcome Data from One Centre Experience with Burosumab
por: Cheung, Moira, et al.
Publicado: (2019)

Wnt pathway inhibitors are upregulated in XLH dental pulp cells in response to odontogenic differentiation
por: Guirado, Elizabeth, et al.
Publicado: (2023)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
por: Kamenicky, Peter, et al.
Publicado: (2023)

THU466 XLH During Pregnancy: A Closer Look Based On Real-World Experience
por: Ali, Dalal S, et al.
Publicado: (2023)

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study
por: Padidela, Raja, et al.
Publicado: (2020)

Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
por: Padidela, Raja, et al.
Publicado: (2020)

Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy
por: Brener, Avivit, et al.
Publicado: (2021)

Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH)
por: Glorieux, Francis H., et al.
Publicado: (2022)

Creation of an Evidence-Based Physical Therapy Program for Adults with XLH: Translational Application of an Interprofessional Clinical Study
por: Kanamalla, Karthik, et al.
Publicado: (2021)

Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH)
por: Ross, Ryan, et al.
Publicado: (2023)

Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH)
por: Carpenter, Kelsey A., et al.
Publicado: (2023)

SUN-524 Burosumab Initiation In A UK XLH Cohort: Real-World Use Resonates With Research Evidence
por: Dharmaraj, Poonam, et al.
Publicado: (2019)

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
por: Ariceta, Gema, et al.
Publicado: (2023)

Relationship between percentage of mean arterial pressure at the ankle and mortality in participants with normal ankle-brachial index: an observational study
por: Li, Yu-Hsuan, et al.
Publicado: (2016)

Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot
por: Dai, Jiezhi, et al.
Publicado: (2022)

OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
por: Imel, Erik, et al.
Publicado: (2019)

PHEX(L222P) Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease
por: El Hakam, Carole, et al.
Publicado: (2022)

Corrigendum: Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot
por: Dai, Jiezhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_js1j0eus7ie9k983ibhf999kpm